During the past decade, Coastal Connecticut Research, LLC conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 20 clinical trials were completed, i.e. on average, 95.2% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 13 clinical trials were completed. i.e. 185.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Coastal Connecticut Research, LLC" #1 sponsor was "GTx" with 3 trials, followed by "Astellas Pharma Global Development, Inc." with 2 trials sponsored, "Biohaven Pharmaceuticals, Inc." with 2 trials sponsored, "Otsuka Pharmaceutical Development & Commercialization, Inc." with 2 trials sponsored and "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 2 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Coastal Connecticut Research, LLC" #1 collaborator was "Alder Biopharmaceuticals, Inc." with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Daré Bioscience, Inc." with 1 trials as a collaborator, "King Pharmaceuticals is now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Coastal Connecticut Research, LLC" are "Hot Flashes" (3 trials), "Menopause" (3 trials), "Stress Urinary Incontinence" (3 trials), "Vulvovaginal Atrophy" (3 trials) and "Agitation in Patients With Dementia of the Alzheimer's Type" (2 trials). Many other conditions were trialed in "Coastal Connecticut Research, LLC" in a lesser frequency.

Most popular intervention types in "Coastal Connecticut Research, LLC" are "Drug" (34 trials), "Other" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "placebo" (4 trials), "AVP-786" (2 trials), "Estradiol" (2 trials) and "GTx-024" (2 trials). Other intervention names were less common.

The vast majority of trials in "Coastal Connecticut Research, LLC" are 21 trials for "All" genders and 15 trials for "Female" genders.

Currently, there are NaN active trials in "Coastal Connecticut Research, LLC". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 23 completed trials in Coastal Connecticut Research, LLC, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Coastal Connecticut Research, LLC, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".